Case Study: Llaama achieves reproducible biopharma research with Akka

Llaama speeds biopharma research to production in weeks with Akka

Llaama, a biopharma company, faced a significant challenge in its research and development processes. The industry loses an estimated USD 7 billion annually due to irreproducible clinical studies, a problem exacerbated by fragmented teams and distributed AI workflows that broke traceability. Llaama needed a solution to create immutable audit trails and ensure reproducibility without spending months on in-house DevOps and database administration. They turned to the vendor Akka to build their T2R2 platform.

By leveraging Akka, Llaama built the T2R2 system, which records every step of an AI or data-science workflow as an immutable audit trail and a directed acyclic graph. This Akka-powered solution provides reproducibility of both workflows and results, preserving data lineage across distributed containers and sites. The platform was delivered in just a few weeks, a task Llaama estimates would have taken months internally, directly addressing the massive annual financial loss from irreproducible studies.

Llaama